Document is current
Any future updates will be listed below
-
Authors
Goodman, Sarah J.
Butcher, Darci T.
Guger, Sharon L.
Diehl, Eric
Brzezinski, Jack
Spiegler, Brenda
Nieman, Brian J.
Kallurkar, Prajkta
Boulet Craig, Aubrée
Krajinovic, Maja
Laniel, Julie
Laverdière, Caroline
Sinnett, Daniel https://orcid.org/0000-0003-3625-6676
Lippé, Sarah
Turinsky, Andrei
Shago, Mary
Strug, Lisa J.
Ito, Shinya
Hitzler, Johann K. https://orcid.org/0000-0003-1158-186X
Schachar, Russell
Weksberg, Rosanna https://orcid.org/0000-0002-6501-4150
-
Funding
Funding for this research was provided by:
Canadian Institutes of Health Research
Leukemia and Lymphoma Society of Canada
Ontario Brain Institute
- License Information
-
More Information
Article History
Received: 12 March 2025
Revised: 23 July 2025
Accepted: 23 September 2025
First Online: 17 October 2025
Competing interests
: R.W. is a consultant for Alamya Health. R.S. sits on the Advisory Board for Otsuka Pharmaceuticals. All other authors declare no competing interests.
: Ethics approval for this study was provided by the Hospital for Sick Children’s Research Ethics Board (REB number: 1000033923). All methods were performed in accordance with the principles of the Declaration of Helsinki. Informed consent/assent was obtained from participants and consent from their parents/guardians when appropriate.
